Feed/Investors/the venture arms of Johnson & Johnson, Merck KGaA and Sanofi

the venture arms of Johnson & Johnson, Merck KGaA and Sanofi

The rounds this investor is named on, who it invests beside, and where it shows up.

Named on one round in the feed.

Since 2026-11-05

ROUNDS

joined, none as lead

ROUNDS JOINED · USD

$133M

across 1 round

LATEST ROUND

Series B · $133M · 2026-11-05

CO-INVESTORS

named beside it

Rounds

[ 1 ]

The rounds this investor is named on, who it invests beside, and where it shows up.

Company	Round	Amount	Announced	Role
T-Therapeutics A biotechnology company developing next-generation T cell receptor (TCR) T cell engager (TCE) therapeutics for cancer and autoimmune diseases	Series B Verified against 4 of 69 sources	$133M	2026-11-05	[ PART ]